Welcome to LookChem.com Sign In|Join Free
  • or
Isocyanic acid 3,4-dichlorophenyl ester, also known as 3,4-dichlorophenyl isocyanate, is a white to yellow low melting solid with chemical properties that make it a valuable chemical intermediate and component in organic synthesis. It is combustible and generally insoluble in water, with some reactivity.

102-36-3

Post Buying Request

102-36-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

102-36-3 Usage

Uses

Used in Chemical Synthesis:
Isocyanic acid 3,4-dichlorophenyl ester is used as a chemical intermediate for the synthesis of various compounds, including substituted urea derivatives, 1,5-disubstituted-2-thiobiuret derivatives, and methyl-labeled diuron. It is particularly useful in the preparation of these compounds due to its reactivity and versatility in organic synthesis.
Used in Pesticide Synthesis:
Isocyanic acid 3,4-dichlorophenyl ester is used as a key component in the synthesis of methyl-labeled diuron, a herbicide used in agriculture to control a wide range of broadleaf and grassy weeds. The ester's reactivity allows for the efficient preparation of this herbicide, contributing to its effectiveness in controlling unwanted plant growth.
Used in Pharmaceutical Synthesis:
Isocyanic acid 3,4-dichlorophenyl ester is used as a starting material in the synthesis of substituted urea derivatives, which have potential applications in the pharmaceutical industry. These derivatives can be further modified to create new drugs with various therapeutic properties.
Used in Organic Chemistry Research:
Isocyanic acid 3,4-dichlorophenyl ester is used as a reagent in the synthesis of 1,5-disubstituted-2-thiobiuret derivatives, which are of interest in organic chemistry research. The ester's unique properties allow for the exploration of new chemical reactions and the development of novel compounds with potential applications in various fields.
Used in the Synthesis of Chiral Compounds:
Isocyanic acid 3,4-dichlorophenyl ester is used in the synthesis of Rand S-isomers and RS-racemate of MBPU (3-(3,4-dichlorophenyl)-1,1-dimethylurea). The ability to produce these chiral compounds is important for the development of enantiomerically pure drugs, which can have different biological activities and may be more effective or have fewer side effects than their racemic counterparts.

Reactivity Profile

Isocyanates and thioisocyanates, such as Isocyanic acid 3,4-dichlorophenyl ester, are incompatible with many classes of compounds, reacting exothermically to release toxic gases. Reactions with amines, aldehydes, alcohols, alkali metals, ketones, mercaptans, strong oxidizers, hydrides, phenols, and peroxides can cause vigorous releases of heat. Acids and bases initiate polymerization reactions in these materials. Some isocyanates react with water to form amines and liberate carbon dioxide.

Health Hazard

Strong irritant to tissue, especially eyes and mucous membranes

Fire Hazard

Inhalation of dust is poisonous; fire may produce irritating or poisonous gases.

Flammability and Explosibility

Notclassified

Potential Exposure

Those materials used as chemical intermediates

Shipping

UN2250 Dichlorophenyl isocyanates, Hazard Class: 6.1; Labels: 6.1-Poisonous materials.

Incompatibilities

May form explosive mixture with air. Isocyanates are highly flammable and reactive with many compounds, even with themselves. Incompatible with oxidizers (chlorates, nitrates, peroxides, permanganates, perchlorates, chlorine, bromine, fluorine, etc.); contact may cause fires or explosions. Reaction with moist air, water or alcohols may form amines and insoluble polyureas and react exothermically, releasing toxic, corrosive or flammable gases, including carbon dioxide; and, at the same time, may generate a violent release of heat increasing theconcentration of fumes in the air. Incompatible with amines, aldehydes, alkali metals, ammonia, carboxylic acids, caprolactum, alkaline materials, glycols, ketones, mercaptans, hydrides, organotin catalysts, phenols, strong acids, strong bases, strong reducing agents such as hydrides, urethanes, and ureas. Elevated temperatures or contact with acids, bases, tertiary amines, and acylchlorides may cause explosive polymerization. Contact with metals may evolve flammable hydrogen gas. Attacks some plastics, rubber, and coatings.

Waste Disposal

Combustion in an incinerator equipped with afterburner and fume scrubber

Check Digit Verification of cas no

The CAS Registry Mumber 102-36-3 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 1,0 and 2 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 102-36:
(5*1)+(4*0)+(3*2)+(2*3)+(1*6)=23
23 % 10 = 3
So 102-36-3 is a valid CAS Registry Number.
InChI:InChI=1/C7H3Cl2NO/c8-6-2-1-5(10-4-11)3-7(6)9/h1-3H

102-36-3 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (A16298)  3,4-Dichlorophenyl isocyanate, 97%   

  • 102-36-3

  • 5g

  • 378.0CNY

  • Detail
  • Alfa Aesar

  • (A16298)  3,4-Dichlorophenyl isocyanate, 97%   

  • 102-36-3

  • 25g

  • 1286.0CNY

  • Detail
  • Aldrich

  • (245607)  3,4-Dichlorophenylisocyanate  97%

  • 102-36-3

  • 245607-10G

  • 913.77CNY

  • Detail

102-36-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name Isocyanic acid 3,4-dichlorophenyl ester

1.2 Other means of identification

Product number -
Other names 3,4-DICHLOROPHENYLCARBIMIDE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:102-36-3 SDS

102-36-3Synthetic route

bis(trichloromethyl) carbonate
32315-10-9

bis(trichloromethyl) carbonate

m,p-dichloroaniline
95-76-1

m,p-dichloroaniline

3,4-dichlorophenylisocyanate
102-36-3

3,4-dichlorophenylisocyanate

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 20℃;96%
In 1,2-dichloro-ethane at 70 - 83℃;91.9%
With triethylamine In benzene for 3h; Heating;
phosgene
75-44-5

phosgene

m,p-dichloroaniline
95-76-1

m,p-dichloroaniline

3,4-dichlorophenylisocyanate
102-36-3

3,4-dichlorophenylisocyanate

Conditions
ConditionsYield
With bis(trichloromethyl) carbonate at 80℃; for 3.3h; Temperature;94%
With ethyl acetate
With sodium hydrogencarbonate In dichloromethane; water; toluene at 0 - 20℃;
3,4-dichloronitrobenzene
99-54-7

3,4-dichloronitrobenzene

carbon monoxide
201230-82-2

carbon monoxide

3,4-dichlorophenylisocyanate
102-36-3

3,4-dichlorophenylisocyanate

Conditions
ConditionsYield
With pyridine; rhodium(III) chloride; bis(acetylacetonate)oxovanadium; 1-methyl-4-nitrobenzene; Azobenzene In chlorobenzene at 175℃; under 60004.8 Torr; for 1h; Product distribution; other reagents;
With pyridine; palladium dichloride In chlorobenzene at 160℃; under 76000 Torr; for 1h; Product distribution; other temperature, effects of adding Fe, V, Mo compounds and other additives on the conversion and selectivity of reaction;
With N,N-diphenylaminobenzene; palladium dichloride at 200℃; under 76000 Torr; Product distribution; selectivity of reaction, combined carbonylation with 3-chloronitrobenzene and azobenzene, influence of bases, salts;
DCMU
330-54-1

DCMU

A

dimethyl amine
124-40-3

dimethyl amine

B

3,4-dichlorophenylisocyanate
102-36-3

3,4-dichlorophenylisocyanate

Conditions
ConditionsYield
at 170 - 220℃; Thermodynamic data; ΔH; heat of dissociation;
With hydrogenchloride; potassium chloride at 60.1℃; Kinetics; Further Variations:; Reagents; pH-values;
3-Methyl-pyrazole-1-carboxylic acid (3,4-dichloro-phenyl)-amide
69413-37-2

3-Methyl-pyrazole-1-carboxylic acid (3,4-dichloro-phenyl)-amide

A

3-Methylpyrazole
1453-58-3

3-Methylpyrazole

B

3,4-dichlorophenylisocyanate
102-36-3

3,4-dichlorophenylisocyanate

Conditions
ConditionsYield
With dibutylamine In tetrachloromethane at 40℃; Rate constant;
In 1,4-dioxane at 40℃; Rate constant; var. aprotic solvents;
ethyl (3,4-dichlorophenyl)carbamate
7159-94-6

ethyl (3,4-dichlorophenyl)carbamate

3,4-dichlorophenylisocyanate
102-36-3

3,4-dichlorophenylisocyanate

Conditions
ConditionsYield
With boron trichloride; triethylamine In benzene for 0.5h; Heating;97 % Chromat.
methyl N-(3,4-dichlorophenyl)carbamate
1918-18-9

methyl N-(3,4-dichlorophenyl)carbamate

3,4-dichlorophenylisocyanate
102-36-3

3,4-dichlorophenylisocyanate

Conditions
ConditionsYield
With boron trichloride; triethylamine In benzene for 0.5h; Heating;87 % Chromat.
1-Butyl-3-(3,4-dichlorophenyl)-1-methylurea
555-37-3

1-Butyl-3-(3,4-dichlorophenyl)-1-methylurea

A

N-n-butyl-N-methylamine
110-68-9

N-n-butyl-N-methylamine

B

3,4-dichlorophenylisocyanate
102-36-3

3,4-dichlorophenylisocyanate

Conditions
ConditionsYield
With hydrogenchloride; potassium chloride at 60.1℃; Kinetics; Further Variations:; Reagents;
3,4-dichlorobenzoyl chloride
3024-72-4

3,4-dichlorobenzoyl chloride

3,4-dichlorophenylisocyanate
102-36-3

3,4-dichlorophenylisocyanate

Conditions
ConditionsYield
With sodium azide In toluene for 1h; Heating;
Multi-step reaction with 2 steps
1: sodium azide / acetone / 0.5 h / 0 °C
2: toluene / 1 h / 100 °C / Reflux
View Scheme
3,4-dichlorbenzoic acid
51-44-5

3,4-dichlorbenzoic acid

Nα-Fmoc-Nim-tert-butyloxycarbonyl-L-tryptophan 4-hydroxymethylphenoxy resin

Nα-Fmoc-Nim-tert-butyloxycarbonyl-L-tryptophan 4-hydroxymethylphenoxy resin

3,4-dichlorophenylisocyanate
102-36-3

3,4-dichlorophenylisocyanate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: thionyl chloride
2: sodium azide / toluene / 1 h / Heating
View Scheme
3,4-dichlorobenzoyl azide
6112-01-2

3,4-dichlorobenzoyl azide

3,4-dichlorophenylisocyanate
102-36-3

3,4-dichlorophenylisocyanate

Conditions
ConditionsYield
In toluene at 100℃; for 1h; Reflux;
bis(2-trimethylsilyloxylethyl)amine
20836-40-2

bis(2-trimethylsilyloxylethyl)amine

3,4-dichlorophenylisocyanate
102-36-3

3,4-dichlorophenylisocyanate

N'-(3,4-Dichlorophenyl)-N,N-bis<2-(trimethylsiloxy)ethyl>urea

N'-(3,4-Dichlorophenyl)-N,N-bis<2-(trimethylsiloxy)ethyl>urea

Conditions
ConditionsYield
In benzene for 1h; Heating;100%
2-(trimethylsiloxy)-N-(trimethylsilyl)ethylamine
17165-52-5

2-(trimethylsiloxy)-N-(trimethylsilyl)ethylamine

3,4-dichlorophenylisocyanate
102-36-3

3,4-dichlorophenylisocyanate

N'-(3,4-dichlorophenyl)-N-<2-(trimethylsiloxy)ethyl>-N-(trimethylsilyl)urea

N'-(3,4-dichlorophenyl)-N-<2-(trimethylsiloxy)ethyl>-N-(trimethylsilyl)urea

Conditions
ConditionsYield
In benzene Heating;100%
3,4-dichlorophenylisocyanate
102-36-3

3,4-dichlorophenylisocyanate

6,7-dimethoxy-4-(1-piperazinyl)quinazoline
21584-72-5

6,7-dimethoxy-4-(1-piperazinyl)quinazoline

N-(3,4-Dichlorophenyl)-4-(6,7-dimethoxy-4-quinazolinyl)-1-piperazinecarboxamide

N-(3,4-Dichlorophenyl)-4-(6,7-dimethoxy-4-quinazolinyl)-1-piperazinecarboxamide

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 20℃;100%
(3S)-3-aminomethyl-4-(4-[3-(2-methoxybenzyloxy)propoxy]phenyl)-5-oxopiperazine-1-carboxylic acid tert-butyl ester
777934-64-2

(3S)-3-aminomethyl-4-(4-[3-(2-methoxybenzyloxy)propoxy]phenyl)-5-oxopiperazine-1-carboxylic acid tert-butyl ester

3,4-dichlorophenylisocyanate
102-36-3

3,4-dichlorophenylisocyanate

(3S)-3-[3-(3,4-dichlorophenyl)ureidomethyl]-(4-[3-(2-methoxybenzyloxy)propoxy]phenyl)-5-oxopiperazine-1-carboxylic acid tert-butyl ester
777934-68-6

(3S)-3-[3-(3,4-dichlorophenyl)ureidomethyl]-(4-[3-(2-methoxybenzyloxy)propoxy]phenyl)-5-oxopiperazine-1-carboxylic acid tert-butyl ester

Conditions
ConditionsYield
In dichloromethane at 20℃; for 18h;100%
4-[(1-ethylpiperidin-3-yl)methyl]piperidin-4-ol dihydrochloride

4-[(1-ethylpiperidin-3-yl)methyl]piperidin-4-ol dihydrochloride

3,4-dichlorophenylisocyanate
102-36-3

3,4-dichlorophenylisocyanate

N-(3,4-dichlorophenyl)-4-[(1-ethylpiperidin-3-yl)methyl]-4-hydroxypiperidine-1-carboxamide

N-(3,4-dichlorophenyl)-4-[(1-ethylpiperidin-3-yl)methyl]-4-hydroxypiperidine-1-carboxamide

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In dichloromethane; N,N-dimethyl-formamide for 0.166667h;100%
3,4-dichlorophenylisocyanate
102-36-3

3,4-dichlorophenylisocyanate

1,3,5-Tris-(3,4-dichloro-phenyl)-[1,3,5]triazinane-2,4,6-trione

1,3,5-Tris-(3,4-dichloro-phenyl)-[1,3,5]triazinane-2,4,6-trione

Conditions
ConditionsYield
With tetrabutylammonium phthalimide-N-oxyl at 50℃; for 0.00833333h; Neat (no solvent);99%
With potassium phthalimide N-oxide at 70℃; for 0.0666667h;97%
With 1,5,7-triazabicyclo[4.4.0]dec-5-enium acetate at 50℃; for 0.00388889h;95%
ethyl 4,5,6,7-tetrahydroisoxazolo[4,5-c]pyridine-3-carboxylate
912330-17-7

ethyl 4,5,6,7-tetrahydroisoxazolo[4,5-c]pyridine-3-carboxylate

3,4-dichlorophenylisocyanate
102-36-3

3,4-dichlorophenylisocyanate

ethyl 5-(3,4-dichlorophenylcarbamoyl)-4,5,6,7-tetrahydroisoxazolo[4,5-c]pyridine-3-carboxylate
1239953-30-0

ethyl 5-(3,4-dichlorophenylcarbamoyl)-4,5,6,7-tetrahydroisoxazolo[4,5-c]pyridine-3-carboxylate

Conditions
ConditionsYield
In toluene for 2h; Reflux;99%
2-amino-6-methyl-4-chloropyrimidine
5600-21-5

2-amino-6-methyl-4-chloropyrimidine

3,4-dichlorophenylisocyanate
102-36-3

3,4-dichlorophenylisocyanate

1-(4-chloro-6-methyl-2-pyrimidinyl)-3-(3,4-dichlorophenyl)urea

1-(4-chloro-6-methyl-2-pyrimidinyl)-3-(3,4-dichlorophenyl)urea

Conditions
ConditionsYield
In toluene for 15h; Inert atmosphere; Reflux;99%
In 1,4-dioxane for 15h; Reflux;69%
dimethyl amine
124-40-3

dimethyl amine

3,4-dichlorophenylisocyanate
102-36-3

3,4-dichlorophenylisocyanate

DCMU
330-54-1

DCMU

Conditions
ConditionsYield
In toluene at 5 - 12℃; Temperature; Inert atmosphere; Green chemistry;98.3%
1,2,3,4-thiatriazole-5-amine
6630-99-5

1,2,3,4-thiatriazole-5-amine

3,4-dichlorophenylisocyanate
102-36-3

3,4-dichlorophenylisocyanate

1-(3,4-Dichloro-phenyl)-3-[2-(3,4-dichloro-phenyl)-3-oxo-2,3-dihydro-[1,2,4]thiadiazol-5-yl]-urea
119872-20-7

1-(3,4-Dichloro-phenyl)-3-[2-(3,4-dichloro-phenyl)-3-oxo-2,3-dihydro-[1,2,4]thiadiazol-5-yl]-urea

Conditions
ConditionsYield
In pyridine at 10 - 15℃; for 24h;98%
3,4-dichlorophenylisocyanate
102-36-3

3,4-dichlorophenylisocyanate

(R)-2-(4-Methoxy-benzylamino)-propionic acid 4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoro-undecyl ester

(R)-2-(4-Methoxy-benzylamino)-propionic acid 4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoro-undecyl ester

(R)-3-(3,4-Dichloro-phenyl)-1-(4-methoxy-benzyl)-5-methyl-imidazolidine-2,4-dione

(R)-3-(3,4-Dichloro-phenyl)-1-(4-methoxy-benzyl)-5-methyl-imidazolidine-2,4-dione

Conditions
ConditionsYield
Stage #1: 3,4-dichlorophenylisocyanate; (R)-2-(4-Methoxy-benzylamino)-propionic acid 4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoro-undecyl ester With triethylamine In dichloromethane at 25℃; for 2h;
Stage #2: With Amberlite G-50 ion-exchange resin; fluorous reverse-phase silica In dichloromethane
98%
3,4-dichlorophenylisocyanate
102-36-3

3,4-dichlorophenylisocyanate

methyl N-[5(6)-(4-aminophenylsulfanyl)benzimidazol-2-yl]carbamate
56073-96-2

methyl N-[5(6)-(4-aminophenylsulfanyl)benzimidazol-2-yl]carbamate

(5-{4-[3-(3,4-dichloro-phenyl)-ureido]-phenylsulfanyl}-1H-benzoimidazol-2-yl)-carbamic acid methyl ester
209803-72-5

(5-{4-[3-(3,4-dichloro-phenyl)-ureido]-phenylsulfanyl}-1H-benzoimidazol-2-yl)-carbamic acid methyl ester

Conditions
ConditionsYield
In dimethyl sulfoxide at 20℃;98%
3,4-dichlorophenylisocyanate
102-36-3

3,4-dichlorophenylisocyanate

(2E)-4-{[(tert-butyl)diphenylsilyl]oxy}-3-methylbut-2-en-1-ol
929897-51-8

(2E)-4-{[(tert-butyl)diphenylsilyl]oxy}-3-methylbut-2-en-1-ol

(2E)-4-(tert-butyl(diphenyl)silyloxy)-3-methylbut-2-en-1-yl (3,4-dichlorophenyl)carbamate
1009734-59-1

(2E)-4-(tert-butyl(diphenyl)silyloxy)-3-methylbut-2-en-1-yl (3,4-dichlorophenyl)carbamate

Conditions
ConditionsYield
With triethylamine In dichloromethane at 20℃;98%
3-aminoindazole
874-05-5

3-aminoindazole

3,4-dichlorophenylisocyanate
102-36-3

3,4-dichlorophenylisocyanate

N-(3,4-dichlorophenyl)-3-(([(3,4-dichlorophenyl)amino]carbonyl)amino)-1H-indazole-1-carboxamide
1119859-99-2

N-(3,4-dichlorophenyl)-3-(([(3,4-dichlorophenyl)amino]carbonyl)amino)-1H-indazole-1-carboxamide

Conditions
ConditionsYield
In tetrahydrofuran at 20℃; Reflux;98%
(4-Thiazolidin-2-yl-phenyl)-carbamic acid ethyl ester
84832-85-9

(4-Thiazolidin-2-yl-phenyl)-carbamic acid ethyl ester

3,4-dichlorophenylisocyanate
102-36-3

3,4-dichlorophenylisocyanate

{4-[3-(3,4-Dichloro-phenylcarbamoyl)-thiazolidin-2-yl]-phenyl}-carbamic acid ethyl ester
84832-95-1

{4-[3-(3,4-Dichloro-phenylcarbamoyl)-thiazolidin-2-yl]-phenyl}-carbamic acid ethyl ester

Conditions
ConditionsYield
In benzene for 1h; Heating;97.5%
3,4-dichlorophenylisocyanate
102-36-3

3,4-dichlorophenylisocyanate

methyl N-[5(6)-(4-aminophenylsulfanyl)benzimidazol-2-yl]carbamate
56073-96-2

methyl N-[5(6)-(4-aminophenylsulfanyl)benzimidazol-2-yl]carbamate

(1-(3,4-dichloro-phenylcarbamoyl)-5-{4-[3-(3,4-dichloro-phenyl)-ureido]-phenylsulfanyl}-1H-benzoimidazol-2-yl)-carbamic acid methyl ester

(1-(3,4-dichloro-phenylcarbamoyl)-5-{4-[3-(3,4-dichloro-phenyl)-ureido]-phenylsulfanyl}-1H-benzoimidazol-2-yl)-carbamic acid methyl ester

Conditions
ConditionsYield
In dimethyl sulfoxide at 70 - 80℃; for 3h;97.1%
methyl 3-(2-amino-6-nitroquinazolin-4ylamino)propanoate
1308319-97-2

methyl 3-(2-amino-6-nitroquinazolin-4ylamino)propanoate

3,4-dichlorophenylisocyanate
102-36-3

3,4-dichlorophenylisocyanate

methyl 3-(2-(3-(3,4-dichlorophenyl)ureido)-6-nitroquinazolin-4-ylamino)propanoate
1308320-05-9

methyl 3-(2-(3-(3,4-dichlorophenyl)ureido)-6-nitroquinazolin-4-ylamino)propanoate

Conditions
ConditionsYield
In 1,4-dioxane at 120℃; for 0.0833333h; Microwave irradiation;97%
tert-butyl 3-((pyridin-3-yloxy)methyl)piperazine-1-carboxylate
960535-17-5

tert-butyl 3-((pyridin-3-yloxy)methyl)piperazine-1-carboxylate

3,4-dichlorophenylisocyanate
102-36-3

3,4-dichlorophenylisocyanate

C22H26Cl2N4O4
1609464-51-8

C22H26Cl2N4O4

Conditions
ConditionsYield
In dichloromethane for 1h;97%
2-methyl-2-methylaminopropionaldoxime
77454-92-3

2-methyl-2-methylaminopropionaldoxime

3,4-dichlorophenylisocyanate
102-36-3

3,4-dichlorophenylisocyanate

1-(3,4-Dichloro-phenyl)-5-hydroxyamino-3,4,4-trimethyl-imidazolidin-2-one
88235-68-1

1-(3,4-Dichloro-phenyl)-5-hydroxyamino-3,4,4-trimethyl-imidazolidin-2-one

Conditions
ConditionsYield
With sodium hydroxide In water Heating;96%
3,4-dichlorophenylisocyanate
102-36-3

3,4-dichlorophenylisocyanate

5-hydroxy-3-methylpyrazole
132712-71-1, 4344-87-0, 145091-87-8

5-hydroxy-3-methylpyrazole

5-Hydroxy-3-methyl-pyrazole-1-carboxylic acid (3,4-dichloro-phenyl)-amide
85220-08-2

5-Hydroxy-3-methyl-pyrazole-1-carboxylic acid (3,4-dichloro-phenyl)-amide

Conditions
ConditionsYield
In chloroform for 15h; Ambient temperature;96%
3,4-dichlorophenylisocyanate
102-36-3

3,4-dichlorophenylisocyanate

ethylhydrazine carboxylate
4114-31-2

ethylhydrazine carboxylate

C10H11Cl2N3O3

C10H11Cl2N3O3

Conditions
ConditionsYield
for 0.0333333h; microwave irradiation;96%
at 20℃; for 0.5h;96%
pyridine
110-86-1

pyridine

dimethyl acetylenedicarboxylate
762-42-5

dimethyl acetylenedicarboxylate

3,4-dichlorophenylisocyanate
102-36-3

3,4-dichlorophenylisocyanate

1-(3,4-dichloro-phenyl)-2-oxo-1,9a-dihydro-2H-pyrido[1,2-a]pyrimidine-3,4-dicarboxylic acid dimethyl ester

1-(3,4-dichloro-phenyl)-2-oxo-1,9a-dihydro-2H-pyrido[1,2-a]pyrimidine-3,4-dicarboxylic acid dimethyl ester

Conditions
ConditionsYield
Stage #1: pyridine; 3,4-dichlorophenylisocyanate In dichloromethane
Stage #2: dimethyl acetylenedicarboxylate In dichloromethane at -5℃; for 0.166667h;
Stage #3: In dichloromethane at 20℃; for 2h; Further stages.;
96%
4-(3-Aminopropyl)morpholine
123-00-2

4-(3-Aminopropyl)morpholine

3,4-dichlorophenylisocyanate
102-36-3

3,4-dichlorophenylisocyanate

1-(3,4-dichlorophenyl)-3-(3-morpholinopropyl)urea

1-(3,4-dichlorophenyl)-3-(3-morpholinopropyl)urea

Conditions
ConditionsYield
With 1,4-diaza-bicyclo[2.2.2]octane In tetrahydrofuran at 20℃;96%
3,4-dichlorophenylisocyanate
102-36-3

3,4-dichlorophenylisocyanate

5-amino-3-benzylthio-4-ethoxycarbonyl-1H-pyrazol
133863-84-0

5-amino-3-benzylthio-4-ethoxycarbonyl-1H-pyrazol

5-Amino-3-benzylsulfanyl-1-(3,4-dichloro-phenylcarbamoyl)-1H-pyrazole-4-carboxylic acid ethyl ester
172845-73-7

5-Amino-3-benzylsulfanyl-1-(3,4-dichloro-phenylcarbamoyl)-1H-pyrazole-4-carboxylic acid ethyl ester

Conditions
ConditionsYield
In tetrahydrofuran Ambient temperature;95.1%
(hydroxy-phenyl-methyl)-phosphonic acid diisopropyl ester
20386-43-0

(hydroxy-phenyl-methyl)-phosphonic acid diisopropyl ester

3,4-dichlorophenylisocyanate
102-36-3

3,4-dichlorophenylisocyanate

[(3,4-Dichloro-phenylcarbamoyloxy)-phenyl-methyl]-phosphonic acid diisopropyl ester

[(3,4-Dichloro-phenylcarbamoyloxy)-phenyl-methyl]-phosphonic acid diisopropyl ester

Conditions
ConditionsYield
With triethylamine In benzene at 50 - 60℃;95%
(Z)-trimethylsilyl N-trimethylsilylacetimidate
10416-59-8, 132255-83-5

(Z)-trimethylsilyl N-trimethylsilylacetimidate

3,4-dichlorophenylisocyanate
102-36-3

3,4-dichlorophenylisocyanate

1,3-Bis(3,4-dichlorphenyl)-6-methyl-5-trimethylsilyl-6-trimethylsilyloxy-1,3,5-triazinan-2,4-dion
96088-24-3

1,3-Bis(3,4-dichlorphenyl)-6-methyl-5-trimethylsilyl-6-trimethylsilyloxy-1,3,5-triazinan-2,4-dion

Conditions
ConditionsYield
In cyclohexane for 16h; Ambient temperature;95%
1,5,5-trimethyl-3-phenyl-4-hydroxylaminoimidazolidin-2-one
88235-70-5

1,5,5-trimethyl-3-phenyl-4-hydroxylaminoimidazolidin-2-one

3,4-dichlorophenylisocyanate
102-36-3

3,4-dichlorophenylisocyanate

C19H20Cl2N4O3
132373-10-5

C19H20Cl2N4O3

Conditions
ConditionsYield
In acetone95%
2-Amino-9,10-dimethoxy-1,3,4,6,7,11b-hexahydrobenzoquinolizine-2-carbonitrile
133308-74-4, 136334-26-4

2-Amino-9,10-dimethoxy-1,3,4,6,7,11b-hexahydrobenzoquinolizine-2-carbonitrile

3,4-dichlorophenylisocyanate
102-36-3

3,4-dichlorophenylisocyanate

(+/-)-2R*,11bS*-N-(2-Cyano-9,10-dimethoxy-1,3,4,6,7,11b-hexahydrobenzoquinolizin-2-yl)-N'-(3
133308-65-3, 136334-35-5

(+/-)-2R*,11bS*-N-(2-Cyano-9,10-dimethoxy-1,3,4,6,7,11b-hexahydrobenzoquinolizin-2-yl)-N'-(3",4"-dichlorophenyl)urea

Conditions
ConditionsYield
In benzene for 2h; Ambient temperature;95%
2-Amino-9,10-dimethoxy-1,3,4,6,7,11b-hexahydrobenzoquinolizine-2-carbonitrile
133308-74-4, 136334-26-4

2-Amino-9,10-dimethoxy-1,3,4,6,7,11b-hexahydrobenzoquinolizine-2-carbonitrile

3,4-dichlorophenylisocyanate
102-36-3

3,4-dichlorophenylisocyanate

(+/-)-2R*,11bS*-3'-(3-2'-one" class="lazyload" data-src="//file1.lookchem.com/cas/reactions/2021/06/07/4831391.png_ms" src="/Databaselist/images/loading.webp" />
136334-42-4

(+/-)-2R*,11bS*-3'-(3",4"-Dichlorophenyl)-4'-imino-9,10-dimethoxy-1,3,4,6,7,11b-hexahydrospiroquinolizin-2,5'-imidazolidin>-2'-one

Conditions
ConditionsYield
With triethylamine In benzene for 3h; Ambient temperature; sonication;95%

102-36-3Relevant academic research and scientific papers

Kinetics and mechanism of hydrolysis of phenylureas

Salvestrini, Stefano,Di Cerbo, Paola,Capasso, Sante

, p. 1889 - 1893 (2002)

The hydrolysis of phenylureas has been found to be affected by temperature, pH and buffer concentration. Kinetic evidence suggests that the formation of phenylisocyanate, the initial product in the title reaction, occurs via an intermediate zwitterion. Depending on pH and buffer concentrations, the zwitterion can be produced through three parallel routes: at low pH, specific acid-general base catalysis, followed by slow deprotonation of a nitrogen atom by a general base; at high pH, specific basic-general acid catalysis, followed by slow protonation of a N atom by a general acid; at intermediate pH the reaction proceeds through a proton switch promoted by buffers. Bifunctional acid-base buffers such as HCO3-/CO32-, H2PO42- and CH3COOH/CH3COO- are very efficient catalysts. At high buffer concentration, as well as at pH 12, the breakdown of the zwitterion is rate-determining. The results are discussed in relation to recently published papers reporting different pathways.

Synthesis and in vitro anti-bladder cancer activity evaluation of quinazolinyl-arylurea derivatives

Chen, Jia-Nian,Li, Ting,Cheng, Li,Qin, Tai-Sheng,Sun, Ye-Xiang,Chen, Chu-Ting,He, Yue-Zhen,Liu, Guang,Yao, Di,Wei, Ying,Li, Qiu-Yin,Zhang, Guang-Ji

, (2020)

Based on the structural modification of molecular-targeted agent sorafenib, a series of quinazolinyl-arylurea derivatives were synthesized and evaluated for their anti-proliferative activities against six human cancer cell lines. Compared with other cell lines tested, T24 was more sensitive to most compounds. Compound 7j exhibited the best profile with lower IC50 value and favorable selectivity. In this study, we focused on 7j-induced death forms of T24 cells and tried to elucidate the reason for its potent proliferative inhibitory activity. Compound 7j treatment could trigger three different cell death forms including apoptosis, ferroptosis, and autophagy; which form would occur depended on the concentrations and incubation time of 7j: (1) Lower concentrations within the initial 8 h of 7j treatment led to apoptosis-dependent death. (2) Ferroptosis and autophagy occurred in the case of higher concentrations combining with extended incubation time through effectively regulating the Sxc?/GPx4/ROS and PI3K/Akt/mTOR/ULK1 pathways, respectively. (3) The above death forms were closely associated with intracellular ROS generation and decreased mitochondrial membrane potential induced by 7j. In molecular docking and structure-activity relationship analyses, 7j could bind well to the active site of the corresponding receptor glutathione peroxidase 4 (GPx4). Compound 7j could be a promising lead for molecular-targeted anti-bladder cancer agents’ discovery.

Synthesis process of 3,4-dichlorophenyl isocyanate

-

Paragraph 0026-0031, (2021/02/13)

The invention discloses a synthesis process of 3,4-dichlorophenyl isocyanate. The synthesis process comprises the following steps: adding 3,4-dichloroaniline and a solvent into a reaction kettle to obtain a 3,4-dichloroaniline solution while adding solid phosgene into the reaction kettle, and heating for dissolving; when the temperature of the reaction kettle reaches 60-100 DEG C, controlling thedripping speed through a DCS to start to dropwise add the 3,4-dichloroaniline solution in the step S1, so that 3,4-dichloroaniline and solid phosgene generate 3,4-dichloroaniline hydrochloride and 3,4-dichlorobenzene methylamino acyl chloride in a solvent medium; removing hydrogen chloride from the 3,4-dichlorobenzene methylamino acyl chloride obtained in S3 to obtain 3,4-dichlorophenyl isocyanate, and after dropwise adding is finished, carrying out reflux heat preservation for 1-3 h; and removing the acid-containing solvent at normal pressure, recycling, transferring the concentrated solutionto a rectifying still, and rectifying to obtain the product 3,4-dichlorophenyl isocyanate. According to the invention, green chemicals are used as production raw materials, so that potential safety hazards caused by phosgene leakage are reduced; and common chemical solid phosgene is adopted to replace virulent phosgene to serve as an acylation reagent, and a green degradable ester solvent is adopted as a reaction medium.

Weeding composition compounded by fine glufosinate-ammonium and diuron and preparation method and application thereof

-

Paragraph 0033, (2021/08/07)

The invention provides a weeding composition compounded by fine glufosinate-ammonium and diuron. The weeding composition is characterized by comprising fine glufosinate-ammonium, diuron and other auxiliary agents, and the content of the fine glufosinate-ammonium is 1-60 parts by mass, the content of the diuron is 1-60 parts by mass, and the content of the auxiliary agents is 20-70 parts by mass. By reasonably proportioning the proportions of the fine glufosinate-ammonium and the diuron in the herbicide, the pesticide effect of the herbicide is enhanced, the control effect on weeds in uncultivated areas is superior to the activity of the singly applied components, meanwhile, the control spectrum of the weeds is expanded, the weeding effect is improved, the weeding composition has a prominent comprehensive control effect on gramineous weeds, cyperaceae weeds and broadleaf weeds, and has the advantages of fast effectiveness, long lasting period, delayed herbicide resistance, thorough weeding, low residue, low toxicity, safety, environmental protection and the like.

Disrupting the Conserved Salt Bridge in the Trimerization of Influenza A Nucleoprotein

Woodring, Jennifer L.,Lu, Shao-Hung,Krasnova, Larissa,Wang, Shih-Chi,Chen, Jhih-Bin,Chou, Chiu-Chun,Huang, Yi-Chou,Cheng, Ting-Jen Rachel,Wu, Ying-Ta,Chen, Yu-Hou,Fang, Jim-Min,Tsai, Ming-Daw,Wong, Chi-Huey

supporting information, p. 205 - 215 (2020/01/02)

Antiviral drug resistance in influenza infections has been a major threat to public health. To develop a broad-spectrum inhibitor of influenza to combat the problem of drug resistance, we previously identified the highly conserved E339?R416 salt bridge of the nucleoprotein trimer as a target and compound 1 as an inhibitor disrupting the salt bridge with an EC50 = 2.7 μM against influenza A (A/WSN/1933). We have further modified this compound via a structure-based approach and performed antiviral activity screening to identify compounds 29 and 30 with EC50 values of 110 and 120 nM, respectively, and without measurable host cell cytotoxicity. Compared to the clinically used neuraminidase inhibitors, these two compounds showed better activity profiles against drug-resistant influenza A strains, as well as influenza B, and improved survival of influenza-infected mice.

Synthesis and nematicidal activity of piperazinedione derivatives based on the natural product Barettin

Sun, Haiyang,Li, Hui,Wang, Jiayi,Song, Gonghua

, p. 977 - 980 (2017/11/16)

Nematodes are serious constraints of crop production worldwide. However, the traditional nematicides suffer from the side-effects, including environmental and human toxicity. Herein, more than 70 novel piperazinedione derivatives based on the natural product Barettin were synthesized and evaluated against the root-knot nematode Meloidogyne incognita (M. incognita). While most of synthesized compounds exhibited certain nematicidal activity at high concentration, the best one showed a nematicidal activity of 75% at 2.4 μmol/L.

Pentafluorosulfanyl-containing triclocarban analogs with potent antimicrobial activity

Pujol, Eugènia,Blanco-Cabra, Núria,Julián, Esther,Leiva, Rosana,Torrents, Eduard,Vázquez, Santiago

supporting information, (2018/11/24)

Concerns have been raised about the long-term accumulating effects of triclocarban, a polychlorinated diarylurea widely used as an antibacterial soap additive, in the environment and in human beings. Indeed, the Food and Drug Administration has recently banned it from personal care products. Herein, we report the synthesis, antibacterial activity and cytotoxicity of novel N,N'-diarylureas as triclocarban analogs, designed by reducing one or more chlorine atoms of the former and/or replacing them by the novel pentafluorosulfanyl group, a new bioisostere of the trifluoromethyl group, with growing importance in drug discovery. Interestingly, some of these pentafluorosulfanyl-bearing ureas exhibited high potency, broad spectrum of antimicrobial activity against Gram-positive bacterial pathogens, and high selectivity index, while displaying a lower spontaneous mutation frequency than triclocarban. Some lines of evidence suggest a bactericidal mode of action for this family of compounds.

With anti-tumor effect of a quinazoline-urea derivative and its application (by machine translation)

-

Paragraph 0139-0142; 0165, (2016/11/02)

The present invention relates to a of the general formula (II) anti-tumor function of said quinazoline-urea derivative and its application. The definition of the substituent in the general formula (II) in the specification. This invention, in order to SUO draw non-Buddhist nun and Geftinat compounds as the precursor, retention of SUO draw non-Buddhist nun the pharmocology-carbamido; at the same time, such as in reserved [...] EGFR-TKIs Geftinat, synthesis, and obtain a series of quinazoline-urea derivatives, by the in vitro activity tests, some compounds exhibit excellent anti-tumor activity, such derivatives have high research and utility value. (II). (by machine translation)

N-substituted 2-isonicotinoylhydrazinecarboxamides-new antimycobacterial active molecules

Rychtarcikova, Zuzana,Kratky, Martin,Gazvoda, Martin,Komloova, Marketa,Polanc, Slovenko,Kocevar, Marijan,Stolarikova, Jirina,Vinsova, Jarmila

, p. 3851 - 3868 (2014/05/20)

This report presents a new modification of the isoniazid (INH) structure linked with different anilines via a carbonyl group obtained by two synthetic procedures and with N-substituted 5-(pyridine-4-yl)-1,3,4-oxadiazole-2-amines prepared by their cyclisation. All synthesised derivatives were characterised by IR, NMR, MS and elemental analyses and were evaluated in vitro for their antimycobacterial activity against Mycobacterium tuberculosis H37Rv, Mycobacterium avium 330/88, Mycobacterium kansasii 235/80 and one clinical isolated strain of M. kansasii 6509/96. 2-Isonicotinoyl-N-(4- octylphenyl)hydrazinecarboxamide displayed an in vitro efficacy comparable to that of INH for M. tuberculosis with minimum inhibitory concentrations (MICs) of 1-2 μM. Among the halogenated derivatives, the best anti-tuberculosis activity was found for 2-isonicotinoyl-N-(2,4,6-trichlorophenyl) hydrazinecarboxamide (MIC = 4 μM). In silico modelling on the enoyl-acyl carrier protein reductase InhA confirmed that longer alkyl substituents are advantageous for the interactions and affinity to InhA. Most of the hydrazinecarboxamides, especially those derived from 4-alkylanilines, exhibited significant activity against INH-resistant nontuberculous mycobacteria. gfjh+l;kfldf.

Novel VEGFR-2 kinase inhibitors identified by the back-to-front approach

Sanphanya, Kingkan,Wattanapitayakul, Suvara K.,Phowichit, Suwadee,Fokin, Valery V.,Vajragupta, Opa

, p. 2962 - 2967 (2013/06/27)

We report a novel VEGFR-2 inhibitor, developed by the back-to-front approach. Docking experiments indicated that the 3-chloromethylphenylurea motif of the lead compound occupied the back pocket of VEGFR-2 kinase. An attempt was made to enhance the binding affinity of 1 by expanding the structure to access the front pocket using a triazole linker. A library of 1,4-(disubstituted)-1H-1, 2,3-triazoles were screened in silico, and one compound (VH02) was identified with an IC50 against VEGFR-2 of 0.56 μM. VH02 showed antiangiogenic effects, inhibiting tube formation in HUVEC cells (EA.hy926) at 0.3 μM, 13 times lower than its cytotoxic dose. These enzymatic and cellular activities suggest that VH02 has potential as a lead for further optimization.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 102-36-3